Evidence map›Paper›PMID 36443066›Full record

ArticleThe British journal of general practice : the journal of the Royal College of General Practitioners2023

Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.

Merle Ca Schoofs, Reinier P Akkermans, Wim Jc de Grauw, Bianca Wm Schalk, Ineke van Dis, Judith Tjin-A-Ton, Erik Wma Bischoff, Marion Cj Biermans

Abstract read
In one paragraph

Article in The British journal of general practice : the journal of the Royal College of General Practitioners, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Merle Ca SchoofsDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-0434-9117
Reinier P AkkermansDepartment of Primary and Community Care and Department of IQ healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-0592-4563
Wim Jc de GrauwDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-0795-6983
Bianca Wm SchalkDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-4359-1715
Ineke van DisDutch Heart Foundation, The Hague, the Netherlands.ORCID http://orcid.org/0000-0002-3665-3850
Judith Tjin-A-TonGP practice Frakking & Tjin- A-Ton, Amstelveen, the Netherlands.ORCID http://orcid.org/0000-0002-4206-6396
Erik Wma BischoffDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-3323-8475
Marion Cj BiermansDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0001-5401-3817

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGPs frequently use 10-year-risk estimations of cardiovascular disease (CVD) to identify high- risk patients.

aimTo assess the performance of four models for predicting the 10-year risk of CVD in Dutch general practice. DESIGN AND

settingProspective cohort study. Routine data (2009- 2019) was used from 46 Dutch general practices linked to cause of death statistics.

methodThe outcome measures were fatal CVD for SCORE and first diagnosis of fatal or non- fatal CVD for SCORE fatal and non-fatal (SCORE- FNF), Globorisk-laboratory, and Globorisk-office. Model performance was assessed by examining discrimination and calibration.

resultsThe final number of patients for risk prediction was 1981 for SCORE and SCORE-FNF, 3588 for Globorisk-laboratory, and 4399 for Globorisk- office. The observed percentage of events was 18.6% (

conclusionWide eligibility criteria and a broad outcome measure contribute to the model applicability in daily practice. The restriction to fatal CVD outcomes of SCORE renders it less usable in routine Dutch general practice. The models seriously underestimate the 10-year risk of fatal plus non-fatal CVD in Dutch general practice. The poor model performance is possibly because of differences between patients that are eligible for risk prediction and the population that was used for model development. In addition, selection of higher-risk patients for CVD risk assessment by GPs may also contribute to the poor model performance.

Indexed as

Cardiovascular DiseasesGeneral PracticeHeart Disease Risk FactorsHumansProspective StudiesRisk AssessmentRisk Factorscardiovascular diseaseprimary health careprospective studiesrisk equation

Identifiers

PMID36443066
PMCPMC9710862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.